Alembic Pharmaceuticals Ltd (ALEM.NS) Quote| Reuters.com
Edition:
United States

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

539.00INR
24 Jun 2016
Change (% chg)

Rs1.35 (+0.25%)
Prev Close
Rs537.65
Open
Rs530.00
Day's High
Rs541.65
Day's Low
Rs514.60
Volume
71,751
Avg. Vol
124,162
52-wk High
Rs791.90
52-wk Low
Rs512.50

ALEM.NS

Chart for ALEM.NS

About

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company focuses on anti-infective, analgesic and, cough and cold markets. It also focuses on chronic therapies (cardiology, diabetes, gynecology, gastrointestinal (GI), orthopedic, dermatology and respiratory). Its segments include Active Pharmaceutica... (more)

Overall

Beta: 0.62
Market Cap(Mil.): Rs101,610.10
Shares Outstanding(Mil.): 188.52
Dividend: 4.00
Yield (%): 0.74

Financials

  ALEM.NS Industry Sector
P/E (TTM): 14.12 32.69 34.11
EPS (TTM): 38.17 -- --
ROI: 54.33 15.00 14.23
ROE: 57.90 16.08 15.46

Alembic sues over Mylan's exclusivity period for generic Benicar

Indian generic drugmaker Alembic Pharmaceuticals Ltd has asked a federal court to rule that its proposed generic versions of Daiichi Sankyo Co Ltd's hypertension drugs Benicar and Benicar HCT would not infringe Daiichi's patent.

Apr 05 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.